GSK plc (GSK) ORD GBP0.3125
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
London close: Stocks end turbulent week in the red
15 November 2024 15:21
(Sharecast News) - London stocks ended Friday in negative territory, weighed down by losses in pharmaceutical shares and a surprise slowdown in UK economic growth during the third quarter.
-
GSK's Blenrep shows strong survival benefit in myeloma study
14 November 2024 07:26
(Sharecast News) - GSK reported positive results from its phase three 'DREAMM-7' trial on Thursday, highlighting a significant overall survival benefit for 'Blenrep', or belantamab...
-
London close: Stocks mixed as Chancellor unveils tax hikes
30 October 2024 14:57
(Sharecast News) - London stocks saw mixed results on Wednesday as investors weighed the impact of the £40bn worth of tax rises announced by Rachel Reeves in her first Budget as Chancellor.
-
GSK maintains guidance after mixed third quarter
30 October 2024 07:19
(Sharecast News) - GSK reported a mixed third-quarter performance on Wednesday, with a notable boost from specialty medicines helping to offset weaker sales in vaccines.
-
GSK RSV vaccine shows potential to help protect broader group of adults
24 October 2024 08:43
(Sharecast News) - Drugmaker GSK said on Thursday that new data for its respiratory syncytial virus vaccine showed potential to help protect a broader group of adults at increased risk for RSV disease.
-
GSK UTI treatment gets FDA priority review status
16 October 2024 07:20
(Sharecast News) - GSK announced on Wednesday that the US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for gepotidacin, a first-in-class oral antibiotic, under priority review.
-
GSK reports positive results from depemokimab trial
14 October 2024 07:55
(Sharecast News) - GSK has announced positive results from a phase III trial of its depemokimab treatment for chronic rhinosinusitis with nasal polyps (CRSwNP).
-
London close: Stocks red as US inflation, jobless claims top forecasts
10 October 2024 14:58
(Sharecast News) - London's stock markets ended Thursday in negative territory as investors weighed a higher-than-expected inflation and jobless claims readings out of the United States.
-
London midday: Stocks dip ahead of US inflation reading
10 October 2024 12:10
(Sharecast News) - London stocks had fallen into the red by lunchtime on Thursday, as investors awaited crucial US inflation data, which could influence the Federal Reserve's next policy moves.
-
GSK's Zantac settlement should give stock a boost, says Jefferies
10 October 2024 10:25
(Sharecast News) - GSK's $2.2bn payment to settle 93% of outstanding Zantac lawsuits in the US was close to the "best case scenario", according to Jefferies, which said the announcement should...
-
GSK to pay $2.2bn to settle Zantac lawsuits
10 October 2024 07:37
(Sharecast News) - GSK has agreed to pay $2.2bn to settle about 80,000 Zantac lawsuits in the US.
-
GSK's Arexvy provides protection over three RSV seasons, trial shows
8 October 2024 11:57
(Sharecast News) - GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over...
Company announcements Announcements
-
GSK announces overall survival results for Blenrep
14 November 2024 07:00
GSK
-
Block listing Interim Review
13 November 2024 15:00
GSK
-
Director/PDMR Shareholding
12 November 2024 15:30
GSK
-
GSK publishes provisional 2025 dividend dates
11 November 2024 15:01
GSK
-
Total Voting Rights
1 November 2024 15:00
GSK
-
Director/PDMR Shareholding
30 October 2024 14:29
GSK
-
3rd Quarter Results
30 October 2024 07:00
GSK
-
New positive Arexvy data in younger adults at risk
24 October 2024 07:00
GSK
-
Director/PDMR Shareholding
17 October 2024 15:30
GSK
-
Director/PDMR Shareholding
16 October 2024 16:09
GSK
-
FDA accepts new drug application for gepotidacin
16 October 2024 07:00
GSK
-
Director/PDMR Shareholding
14 October 2024 15:30
GSK
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.